Laboratory Compound Overview
Ibutamoren MK-677 is a non-peptide growth hormone secretagogue developed for advanced laboratory research applications. This orally bioavailable compound functions as a selective ghrelin receptor agonist, enabling researchers at Stroid UK Shop to investigate growth hormone release pathways without affecting cortisol levels in controlled research environments. The compound’s unique molecular structure allows for sustained pulsatile growth hormone secretion studies, making it an essential tool for endocrinological research protocols.
Research Applications
Academic institutions and certified laboratories utilise MK-677 to examine growth hormone deficiency models, sarcopenia research protocols, and metabolic pathway investigations. The compound’s mechanism involves binding to ghrelin receptors, stimulating growth hormone release through hypothalamic-pituitary axis modulation. Researchers studying ibutamoren compounds have documented its potential for investigating age-related growth hormone decline, muscle protein synthesis pathways, and bone density research models. Its oral bioavailability makes it particularly valuable for long-term research studies requiring consistent compound administration protocols. Scientists also examine its effects on IGF-1 elevation and metabolic homeostasis in controlled laboratory settings.
Technical Specifications
| Parameter | Value |
|---|---|
| CAS Number | 159634-47-6 |
| Molecular Formula | C₂₇H₃₆N₄O₅S |
| Molecular Weight | 528.66 g/mol |
| Classification | Growth Hormone Secretagogue |
| Research Grade | Laboratory Standard |
| Storage Conditions | Room temperature, dry environment |
Researchers investigating selective androgen receptor modulators often compare MK-677’s growth hormone pathway effects with other research compounds. The compound demonstrates excellent stability when stored according to specifications, maintaining research integrity throughout extended study periods. Laboratory protocols frequently combine MK-677 research with peptide investigations to examine synergistic effects on growth factor pathways.
Research Compliance Statement
This compound is manufactured exclusively for in-vitro laboratory research applications and is not intended for human consumption, clinical trials, or therapeutic use. Researchers must maintain proper laboratory protocols and safety procedures when handling this research chemical. All studies should be conducted in certified laboratory facilities with appropriate safety measures and documentation protocols in place.
